Clinical correlates of chronic rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study

Transplantation

Volumn 61, Issue 7, 1996, Pages 1054-1058

  Tejani, Amir ^a   Cortes, Lyn ^a   Stablein, Donald ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ARTICLE; CADAVER KIDNEY; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NEGRO; PEDIATRIC SURGERY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; MALE; RISK FACTORS;

EID: 0030005909     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00011     Document Type: Article

References (27)

1. United States Renal Data System. National Institute of Diabetes and Digestive and Kidney Diseases 1993 Annual Report (Table G-7). Bethesda, MD: U.S. Renal Data System .
2. United States Renal Data System. National Institute of Diabetes and Digestive and Kidney Diseases 1993 Annual Report (Table G-19). Bethesda, MD: U.S. Renal Data System.
3. Tejani A, Stablein D, Alexander S, Fine R, Harmon W. Analysis of rejection outcomes and implications: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1995; 59: 500.
4. Denny T, Yogev R, Gelman R, et al. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA 1992; 267: 1484.
5. Bunchman TE, Fryd DS, Sibley RK, Mauer SM. Manifestations of renal allograft rejection in small children receiving adult kidneys. Pediatr Nephrol 1990; 4: 255.
6. Cook D. Long-term survival of kidney allografts. In: Terasaki PI, ed. Clinical transplantation. Los Angeles: UCLA Tissue Typing Laboratory, 1987: 227.
7. Opelz G for the Collaborative Transplant Study. Effect of HLA matching in 10,000 cyclosporin treated cadaver kidney transplants. Transplant Proc 1987; 19: 641.
8. Avner E, Shavers B, Sullivan EK, Tejani A. Renal transplantation and chronic dialysis in children and adolescents: the 1993 annual report of the North American Pediatric Renal Transplantation Cooperative Study. Pediatr Nephrol 1995; 9: 61.
9. Tejani A, Sullivan K, Fine R, Harmon W, Alexander S. Steady improvement in cadaver graft survival among North American children: a five-year appraisal by the NAPRTCS. Kidney Int 1995; 48: 551.
10. McEnery PT, Stablein DM, Arbus G, Tejani A. Renal transplantation in children: a report of NAPRTCS. N Engl J Med 1992; 326: 1727.
11. Tejani A, Fine R, Alexander S, et al. Factors predictive of sustained growth in children after renal transplantation. J Pediatr 1993; 122: 397.
12. Kohaut E, Tejani A. The 1994 NAPRTCS annual report. Pediatr Nephrol (in press).
13. Cecka JM. Early rejection determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
14. Ferguson RM, Henry ML, Elkhammas EA. Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival [Abstract]. Presented at the 18th annual meeting of the American Society of Transplant Surgeons, May 28-29, 1992, Chicago, IL.
15. Foster MC, Rowe PA, Dennis MJS, et al. Characteristics of cadaver allograft recipients developing chronic rejection. Ann R Col Surg Engl 1990; 12: 23.
16. Almond SP, Matas A, Gillingham K, et al. Risk factors of chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
17. Gulanikar AC, MacDonald AS, Sungurtekin U, et al. The incidence and impact of early rejection episodes of graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
18. Tejani A, Sullivan K. Higher doses of cyclosporine prevent graft rejection [Abstract]. J Am Soc Nephrol (in press).
19. Borel JF, Ryfffel B. The mechanism of action of cyclosporine In: R Schindler, ed. Cyclosporine in autoimmune diseases. Berlin: Springer-Verlag.
20. Morris RE, Hoyt EG, Murphy MP, et al. Mycophenolic acid morpholinoethylester (RS-6134) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1169.
21. Terada N, Lucas JJ, Franklin RA. Effects of rapamycin in cell-cycle progression. J Cell Biochem 1992; suppl 16B: 180.
22. Maury CPJ, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med 1987; 166: 1132.
23. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in meningococcal disease. Lancet 1987; 2: 1364.
24. Van Oers MHJ, VanDer Heyden AAPAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 314.
25. Zanetti G, Heumann D, Gerain J, et al. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 1992; 148: 1890.
26. Ingulli E, Tejani A. Racial differences in the incidence and outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991; 5: 393.
27. North American Pediatric Renal Transplant Cooperative Study. The 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study. Brooklyn, NY: Clinical Coordinating Center.